Júlio Teixeira Introduces New Harmony Pro Linear Accelerator at Hospital de Braga

Júlio Teixeira has successfully brought a new Harmony Pro linear accelerator into clinical operation at Hospital de Braga, marking an important milestone in the ongoing development of radiotherapy services for patients.

Strengthening radiotherapy services in Braga

The Harmony Pro linear accelerator delivers a comprehensive range of external beam radiotherapy techniques, including:

• Three-Dimensional Conformal Radiation Therapy (3D-CRT)
• Intensity-Modulated Radiation Therapy (IMRT)
• Volumetric Modulated Arc Therapy (VMAT)

These techniques allow treatment to be adapted to the size, shape and location of each tumour, helping clinicians target cancer while reducing unnecessary exposure to nearby healthy tissues.

One of the system’s key capabilities is VMAT. During treatment, the linear accelerator rotates around the patient while the dynamic multileaf collimator, dose rate and gantry speed are continuously adjusted. This coordinated delivery enables highly conformal dose distributions and supports accurate, efficient treatment, including for more complex plans.

Commenting on the milestone, José Pedro Ferreira, CEO of Júlio Teixeira, said:

“The introduction of the Harmony Pro linear accelerator represents an important step in the continued evolution of radiotherapy services at Hospital de Braga. By investing in the latest treatment technology and working closely with our colleagues at the hospital, we are strengthening our ability to deliver personalised, high-quality cancer care for patients. This new system expands our clinical capabilities while supporting the precision and efficiency that modern radiotherapy demands.”

Advancing cancer care in Portugal

The clinical go-live of the Harmony Pro reflects Júlio Teixeira’s continued investment in technologies that support evidence-based radiotherapy and improve the treatment experience for patients.

As part of Stingray Healthcare Group, Júlio Teixeira combines more than 30 years of experience in radiotherapy in Portugal with access to a European network of specialist oncology centres, supporting the exchange of clinical expertise and the adoption of new technologies that enhance patient care.